1. Infection

Infection

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14322
    Mollisin 667-92-5
    Mollisin is a quinone antibiotic with antifungal activity.
    Mollisin
  • HY-N14325
    Madindoline B 184877-65-4
    Madindoline B is an IL-6 inhibitor. Madindoline B inhibits IL-6-dependent MH-60 cells and has no inhibitory effect on IL-6-independent MH-60 cells. In the presence of 0.1 U/mL IL-6, it inhibits IL-6-dependent MH-60 cells with an IC50 of 30 μM. Madindoline B has no antimicrobial effect.
    Madindoline B
  • HY-N14327
    Ferensimycin B 135501-80-3
    Ferensimycin B is a polyether antibiotic with anti-Gram-positive bacteria and weak anti-Gram-negative bacteria, fungi and coccidia.
    Ferensimycin B
  • HY-N14329
    Maniwamycin B 122547-71-1
    Maniwamycin B has anti-fungal effect.
    Maniwamycin B
  • HY-N14333
    Halomicin A 56411-51-9
    Halomicin A is an ansamycin antibiotic. Halomicin A has activity against Gram-positive and Gram-negative bacteria (individual).
    Halomicin A
  • HY-N14334
    Halomicin B 54356-09-1
    Halomicin B is an ansamycin antibiotic. Halomicin B has activity against Gram-positive and Gram-negative bacteria (individual).
    Halomicin B
  • HY-N14335
    Halomicin C 64419-06-3
    Halomicin C is an ansamycin antibiotic. Halomicin C has activity against Gram-positive and Gram-negative bacteria (individual).
    Halomicin C
  • HY-N14336
    Halomicin D 56413-94-6
    Halomicin D is an ansamycin antibiotic. Halomicin A has activity against Gram-positive and Gram-negative bacteria (individual).
    Halomicin D
  • HY-N14338
    Sannamycin L 83946-32-1
    Sannamycin L is an aminoglycoside antibiotic. Sannamycin L has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
    Sannamycin L
  • HY-N14341
    Mannosyl glucosaminide 14510-04-4
    Mannosyl glucosaminide is an aminoglycoside antibiotic. Mannosyl glucosaminide has anti-bacterium, mycobacterium and beer yeast effects.
    Mannosyl glucosaminide
  • HY-N14342
    Manumycin E 156250-43-0
    Manumycin E has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin E inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin E
  • HY-N14343
    Manumycin F 156317-47-4
    Manumycin F has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin F inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin F
  • HY-N14344
    Manumycin G 156250-44-1
    Manumycin G has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin G inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin G
  • HY-N14345
    Marcellomycin 63710-10-1
    Marcellomycin is a glycoside and quinone antibiotic. Marcellomycin has anti-Gram-positive bacteria effect, especially has strong effect on streptococcus.
    Marcellomycin
  • HY-N14349
    Asterriquinone 60696-52-8
    Asterriquinone (ARQ), a Asterriquinone analog, is a Grb-2 binding inhibitor. Asterriquinone inhibits the Grb-2 binding activity to tyrosine phosphorylated EGFR, with an IC50 of 8.37 μM. Asterriquinone is a HIV1 reverse transcriptase inhibitor with a Ki of 2.3 μM. Asterriquinone also inhibits Grb-7 and PLC-γ binding activities..
    Asterriquinone
  • HY-N14353
    Papulacandins A 61036-46-2
    Papulacandins A is an antibiotic. Papulacandins A can be found in the fungus Papularia sphaerosperma. Papulacandins A has strong anti-yeast effect, but has no effect on filamentous fungi, bacteria and protozoa.
    Papulacandins A
  • HY-N14359
    Megovalicin B 89759-26-2
    Megovalicin B has the effect against subtilis and E.coli.
    Megovalicin B
  • HY-N14360
    Megovalicin H 115932-37-1
    Megovalicin H has an effect against subtilis and E.coli, and it also has the effect against Pseudomonas aeruginosa.
    Megovalicin H
  • HY-N14364
    Flavipucine 38473-18-6
    Flavipucine (Flavipucin), a glutarimide antibiotic, is found in the strain of Aspergillus flavipes F-2090/7. Flavipucine has antibacterial activity against B. subtilis. Flavipucine has antiprotozoal activity. Flavipucine has cytotoxic activity against several cancer cells.
    Flavipucine
  • HY-N14365
    Sannamycin J 83997-42-6
    Sannamycin J is an aminoglycoside antibiotic. Sannamycin J can be found in Streptomyces sannanensis sp. KC-7038. Sannamycin J has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
    Sannamycin J
Cat. No. Product Name / Synonyms Application Reactivity